Login

Anton Pillay, CEO of Coronation Fund Managers, discusses the company's adjustment to payment processes in a "#PayIn30" initiative. 00:10:00

Share On Facebook Share On Twitter

Anton Pillay, CEO of Coronation Fund Managers,

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
India's Manufacturing Renaissance: A Multi-Decade Opportunity | B.Gopkumar, CEO , Axis Mutual Fund.
00:10:00
Nick Bolton, CEO of Oxford Metrics, discusses the company's earnings and growth in augmented and virtual reality technologies.|Imogen was appointed CEO of Oxford Metrics
00:10:00
Exploring Long-Form Essays in Journalism with Celeste Marcus|Celeste Marcus,Professor,College of Arts and Sciences
00:10:00
Undray Wilks: Reflecting on Black History Month at Morgan Lewis | UNDRAY WILKS - PARTNER of Morgan, Lewis & Bockius LLP
00:10:00
Builds and invests in technologies that help move people|Ben Marcus,Managing Partner,UP Partners
00:10:00
JAG Bhd Stock Analysis: Navigating the Recent Pullback and Future Targets
00:10:00
"Exclusive Conversation: Bob Dhillon, Mainstreet Equity Corp's President & CEO, Speaks with Media India Group"
00:10:00
Sierra Metals: Expanding Operations and Strategic Plans for Growth
00:10:00
TSVC is a US venture capital firm focusing on seed-stage investing over 12 years|Spencer Greene,General Partner,TSVC
00:10:00
Insights into Real Estate Trends: Acquisitions, Build-to-Suit Projects, and Sustainability Considerations | Bill Trimble, CEO, Easterly Government Properties Inc
00:10:00
Cornish Metals Focuses on Bringing South Crofty Tin Project into Production
00:10:00
Hyosung's Expansion in India: A Promising Partnership for Growth | Hyun-Joon Cho, Chairman of Hyosung Corp

© 2026 Nehu